circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer

Table 1

Correlation between the circSMARCA5 expression and clinicopathological features of gastric cancer patients (). The median expression level of the circSMARCA5 expression was used as the cutoff value. Data were analyzed by the Fisher exact test or chi-square test.

Clinicopathological features	Low circSMARCA5 expression ()	High circSMARCA5 expression ()
Age			0.589
<60 years	12	9
≥60 years	18	21
Gender			0.382
Female	6	10
Male	24	20
Tumor location			0.785
Down	19	21
Upper/middle	11	9
Tumor size			0.267
<5 cm	18	23
≥5 cm	12	7
Differentiation			0.019
Well/moderate	9	19
Poor	21	11
Lymph node metastasis			0.015
Negative	6	16
Positive	24	14
Vascular invasion			0.009
No	9	20
Yes	21	10
AJCC stage			0.017
I/II	7	17
III	23	13

indicates statistical significance. AJCC: American Joint Committee on Cancer.